DNP Select Income Fund (DNP) Competitors

iShares Biotechnology ETF (NASDAQ:IBB) and DNP Select Income Fund (NYSE:DNP) are both mid-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, community ranking, media sentiment, risk and dividends.

Is IBB or DNP more profitable?

Company	Net Margins	Return on Equity	Return on Assets
iShares Biotechnology ETF	N/A	N/A	N/A
DNP Select Income Fund	N/A	N/A	N/A

Is IBB or DNP a better dividend stock?

iShares Biotechnology ETF pays an annual dividend of $0.41 per share and has a dividend yield of 0.3%. DNP Select Income Fund pays an annual dividend of $0.71 per share and has a dividend yield of 8.1%.

Which has more risk & volatility, IBB or DNP?

iShares Biotechnology ETF has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500. Comparatively, DNP Select Income Fund has a beta of 0.48, indicating that its stock price is 52% less volatile than the S&P 500.

Do insiders & institutionals believe in IBB or DNP?

62.5% of iShares Biotechnology ETF shares are owned by institutional investors. Comparatively, 8.5% of DNP Select Income Fund shares are owned by institutional investors. 0.1% of DNP Select Income Fund shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Which has higher earnings & valuation, IBB or DNP?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iShares Biotechnology ETF	N/A	N/A	N/A	N/A	N/A
DNP Select Income Fund	N/A	N/A	N/A	N/A	N/A

Does the media prefer IBB or DNP?

In the previous week, iShares Biotechnology ETF and iShares Biotechnology ETF both had 3 articles in the media. iShares Biotechnology ETF's average media sentiment score of 0.55 beat DNP Select Income Fund's score of 0.47 indicating that DNP Select Income Fund is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iShares Biotechnology ETF	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DNP Select Income Fund	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community believe in IBB or DNP?

DNP Select Income Fund received 35 more outperform votes than iShares Biotechnology ETF when rated by MarketBeat users. Likewise, 70.80% of users gave DNP Select Income Fund an outperform vote while only 67.09% of users gave iShares Biotechnology ETF an outperform vote.

Company	Underperform	Outperform
iShares Biotechnology ETF	Outperform Votes 159 67.09%	Underperform Votes 78 32.91%
DNP Select Income Fund	Outperform Votes 194 70.80%	Underperform Votes 80 29.20%

Do analysts rate IBB or DNP?

Given DNP Select Income Fund's higher probable upside, equities analysts plainly believe iShares Biotechnology ETF is more favorable than DNP Select Income Fund.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iShares Biotechnology ETF	0 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.56
DNP Select Income Fund	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

DNP Select Income Fund beats iShares Biotechnology ETF on 5 of the 9 factors compared between the two stocks.